Glenmark Pharmaceuticals (GLENMARK) — Corporate Action

📢 Key Event
Allotment of shares under ESOP 2016

🔄 What Changed
Paid-up capital increased to Rs. 28,22,24,672; total shares rose to 28,22,24,672

💡 Investor Takeaway
This dilutes existing shareholders' ownership proportionally through new share issuance.

Glenmark Pharmaceuticals allotted 23,863 equity shares of Re. 1 each on August 10, 2026, under its Employee Stock Option Plan 2016, increasing paid-up capital to Rs. 28,22,24,672 and total shares to 28,22,24,672, with shares issued at an exercise price of Rs. 600 and premium of Rs. 599, maintaining parity with existing shares.

📄 View Original Announcement (PDF)

📊 Stock Analysis — GLENMARK ✨ Ask AI About This

About Glenmark Pharmaceuticals Limited (GLENMARK)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹68,205.11 Cr P/E: 37.9 ROE: 20.3% ROCE: 24.8% Div Yield: 0.10%

View full GLENMARK stock details →

📡 Get AI alerts when GLENMARK files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GLENMARK — Free

💡 Ask AI about this filing

"How does this ESOP allotment affect Glenmark's EPS and share price?" "What is the current market price of Glenmark shares post-allotment?" "How does this dilution compare to peer companies' employee stock plans?"

Ask AI Free →

📊 More GLENMARK filings

See all GLENMARK filings →

🔥 Also filed on 10 August 2026

TIMKEN Timken India Limited Financial Results DOMS DOMS Industries Limited Corporate Action HGS Hinduja Global Solutions Limited Financial Results SUNDRMFAST Sundram Fasteners Limited Financial Results AMJLAND Amj Land Holdings Limited Annual Report KANSAINER Kansai Nerolac Paints Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GLENMARK files new disclosures

Track GLENMARK filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GLENMARK — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd